Consolidated Statements of Changes in Equity - USD ($)	Common stock As Previously Reported	Common stock	Additional paid-in capital As Previously Reported	Additional paid-in capital	Statutory reserve As Previously Reported	Statutory reserve	Accumulated Deficits As Previously Reported	Accumulated Deficits	Accumulative other comprehensive (loss) As Previously Reported	Accumulative other comprehensive (loss)	Non-controlling interests As Previously Reported	Non-controlling interests	As Previously Reported	Total
Balance at Dec. 31, 2023	$ 446		$ 233,908,386		$ 98,357		$ (185,929,662)		$ (4,094,276)		$ (1,568,207)		$ 42,415,044
Balance (in Shares) at Dec. 31, 2023	445,872
Issuance of common stocks-cash	$ 54		2,580,588										2,580,642
Issuance of common stocks-cash (in Shares)	53,763
Issuance of common stocks-conversion of debt	$ 59		624,941										625,000
Issuance of common stocks-conversion of debt (in Shares)	59,386
Net loss from continuing operations							(33,739,005)						(33,739,005)	$ (33,739,005)
Net income from discontinued operations							(494,837)						(494,837)
Share-based payments-omnibus equity plan	$ 53		670,927										670,980
Share-based payments-omnibus equity plan (in Shares)	52,750
Foreign currency translation adjustment									(307,169)				(307,169)
Disposition of discontinued operation			(286,831)				1,277,970		152,884		(297,859)		846,164
Balance at Dec. 31, 2024	$ 612		$ 237,498,011		$ 98,357		$ (218,885,534)		$ (4,248,561)		$ (1,866,066)		$ 12,596,819	12,596,819
Balance (in Shares) at Dec. 31, 2024	611,771
Issuance of common stocks-cash		$ 3,750		$ 29,996,250										30,000,000
Issuance of common stocks-cash (in Shares)		3,750,000
Issuance of common stocks - Debt Restructuring		$ 110		470,690										470,800
Issuance of common stocks - Debt Restructuring (in Shares)		110,000
Effect to rounding fractional shares into whole shares upon reverse stock split		$ 10		(10)
Effect to rounding fractional shares into whole shares upon reverse stock split (in Shares)		10,620
Pending Equity Settlement				1,282,364										1,282,364
Pre-delivery ordinary shares for conversion of convertible notes payables		$ 361		(361)
Pre-delivery ordinary shares for conversion of convertible notes payables (in Shares)		361,250
Commitment Shares for conversion of convertible notes payables		$ 15		140,385										140,400
Commitment Shares for conversion of convertible notes payables (in Shares)		15,000
Issuance of common stocks-conversion of debt		$ 65		572,681										572,746
Issuance of common stocks-conversion of debt (in Shares)		64,687
Net loss from continuing operations								(30,946,254)						(30,946,254)
Net income from discontinued operations								(119,292)						(119,292)
Share-based payments-omnibus equity plan		$ 125		1,084,875										1,085,000
Share-based payments-omnibus equity plan (in Shares)		125,000
Foreign currency translation adjustment										750,742				750,742
Disposition of discontinued operation								26,445,481		(187,182)		1,866,066		28,124,365
Balance at Dec. 31, 2025		$ 5,048		$ 271,044,885		$ 98,357		$ (223,505,599)		$ (3,685,001)				$ 43,957,690
Balance (in Shares) at Dec. 31, 2025		5,048,328